NYSE:ARE - New York Stock Exchange, Inc. - US0152711091 - REIT - Currency: USD
ALEXANDRIA REAL ESTATE EQUIT
NYSE:ARE (1/27/2025, 5:37:30 PM)
After market: 101.382 -0.73 (-0.71%)102.11
+0.48 (+0.47%)
The current stock price of ARE is 102.11 USD. In the past month the price increased by 2.69%. In the past year, price decreased by -15.93%.
/PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) announced financial and operating results for the fourth quarter and year ended December 31,...
/PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced the tax treatment of its year 2024 distributions as described in the chart...
All three stocks are trading at cheap valuations.
/PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced that the company will conduct a conference call and audio webcast on Tuesday,...
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
WELL | WELLTOWER INC | 91.09 | 86.21B | ||
VTR | VENTAS INC | N/A | 25.93B | ||
DOC | HEALTHPEAK PROPERTIES INC | 45.11 | 14.83B | ||
OHI | OMEGA HEALTHCARE INVESTORS | 28.1 | 10.32B | ||
HR | HEALTHCARE REALTY TRUST INC | N/A | 6.07B | ||
CTRE | CARETRUST REIT INC | 38.57 | 5.19B | ||
AHR | AMERICAN HEALTHCARE REIT INC | N/A | 4.50B | ||
SBRA | SABRA HEALTH CARE REIT INC | 42.54 | 4.13B | ||
DHCNL | DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 | N/A | 3.95B | ||
DHCNI | DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 | N/A | 3.55B | ||
NHI | NATL HEALTH INVESTORS INC | 24.34 | 3.22B | ||
MPW | MEDICAL PROPERTIES TRUST INC | N/A | 2.79B |
Alexandria Real Estate Equities, Inc. engages in the provision of space for lease. The company is headquartered in Pasadena, California and currently employs 568 full-time employees. The firm is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. The company has a Labspace asset base predominantly concentrated in markets with barriers to entry.
ALEXANDRIA REAL ESTATE EQUIT
26 North Euclid Avenue
Pasadena CALIFORNIA 91101 US
CEO: Stephen A. Richardson
Employees: 568
Company Website: https://www.are.com/
Investor Relations: https://investor.are.com
Phone: 16265780777
The current stock price of ARE is 102.11 USD.
The exchange symbol of ALEXANDRIA REAL ESTATE EQUIT is ARE and it is listed on the New York Stock Exchange, Inc. exchange.
ARE stock is listed on the New York Stock Exchange, Inc. exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ARE, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ARE.
ARE has a dividend yield of 5.26%. The yearly dividend amount is currently 4.94.
ARE will report earnings on 2025-01-27, after the market close.
The PE ratio for ARE is 62.26. This is based on the reported non-GAAP earnings per share of 1.64 and the current share price of 102.11 USD.
The outstanding short interest for ARE is 1.79% of its float.
ChartMill assigns a technical rating of 1 / 10 to ARE. When comparing the yearly performance of all stocks, ARE is a bad performer in the overall market: 82.42% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to ARE. While ARE is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months ARE reported a non-GAAP Earnings per Share(EPS) of 1.64. The EPS increased by 17.99% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 8.88% | ||
ROA | 0.73% | ||
ROE | 1.55% | ||
Debt/Equity | 0.7 |
ChartMill assigns a Buy % Consensus number of 73% to ARE. The Buy consensus is the average rating of analysts ratings from 18 analysts.
For the next year, analysts expect an EPS growth of 478.69% and a revenue growth 8.54% for ARE